Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
210,134,362
-
Share change
-
+6,168,458
-
Total reported value
-
$806,046,933
-
Put/Call ratio
-
37%
-
Price per share
-
$3.84
-
Number of holders
-
187
-
Value change
-
+$5,739,854
-
Number of buys
-
81
-
Number of sells
-
84
Institutional Holders of IMMUNOGEN INC - COMMON STOCK (IMGN) as of Q1 2023
As of 31 Mar 2023,
IMMUNOGEN INC - COMMON STOCK (IMGN) was held by
187 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
210,134,362 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, MAVERICK CAPITAL LTD, and MORGAN STANLEY.
This page lists
187
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.